FTIOP
ABEO icon

Fiduciary Trust International of Pennsylvania’s Abeona Therapeutics ABEO Stock Holding History

Fiduciary Trust International of Pennsylvania’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-420
Closed -$67K – 332
2017
Q2 		$67K Buy
+420
New +$57.3K ﹤0.01% 398

Other funds holding ABEO

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Fiduciary Trust International of Pennsylvania's ABEO Position: Q3 2017 in Review

Fiduciary Trust International of Pennsylvania sold out of Abeona Therapeutics (ABEO) in Q3 2017, closing a stake of 420 shares — an estimated $67K sold.

Fiduciary Trust International of Pennsylvania first reported a position in ABEO in Q2 2017 and held it in 1 quarter. The position peaked at $67K in Q2 2017. 75 funds tracked by Wall St. Rank hold ABEO as of Q3 2017.

  • Fiduciary Trust International of Pennsylvania reported no remaining Abeona Therapeutics position as of Q3 2017 after selling out during the quarter.
  • Fiduciary Trust International of Pennsylvania sold 420 Abeona Therapeutics shares in Q3 2017, an estimated $67K.
  • Fiduciary Trust International of Pennsylvania first reported a position in Abeona Therapeutics in Q2 2017 and held it in 1 quarter.
  • Fiduciary Trust International of Pennsylvania's Abeona Therapeutics position peaked at $67K in Q2 2017.
  • 75 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2017.

Based on Fiduciary Trust International of Pennsylvania's 13F filing for Q3 2017, filed 13 Oct 2017.